Merck & company inc

Major-Pharmaceuticals

MRK


2000 Galloping Hill Road
Kenilworth , NJ 07033

Executive/
Director

Price

  • Last Close
  • $ 117.47
    $ +0.09 0.08 %
    Aug 29, 2024
  • 52-Week High/Low
  • $133.1 - $100.17
  • YTD
  • 7.8%

  • Trading Volume
  • 314,323
  • Market Cap Full
  • $ 297.7B
  • Shares Outstanding
  • 2534M
    Oct 31, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 2% 1% 8.7% -2.4% 8.9% -5% -5.5% 7.1% -4.1% 21%
Q2 -0.2% 9.8% 1.6% 14.8% 0.3% 4% 0.6% 11.1% 8.5% -0.4%
Q3 -12.5% 9.1% 0.6% 18.2% 0.5% 8% -3.4% -5.5% -10.7% -
Q4 7.9% -5% -12.1% 7.6% 7.1% -1.4% 2% 28.8% 6.3% -
J F M A M J J A S O N D
2024 10.7% 5.3% 3.8% -1.2% - - - - - - - -
2023 -3.2% -1.1% 0.1% 8.6% -4.4% 4.5% -7.5% 2.2% -5.5% -0.3% -0.2% 6.4%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    17%-4%15%-1%40%18%-10%-6%45%-2%8%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.85 0.89 0.88 0.27 1.12 1.26 1.25 1.7 1.11
Q2 0.86 0.93 1.01 0.63 1.03 1.18 0.61 1.55 -2.35
Q3 0.96 1.07 1.11 0.73 0.74 1.16 1.8 1.28 1.86
Q4 0.93 0.89 0.98 0.69 0.92 -0.83 1.48 1.18 -
A 3.6 3.8 4 2.3 3.8 2.8 5.1 5.7 0.62

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Dividend +

Dividend +

2019 2020 2021 2022 2023 2024
Q1 0.55 0.61 0.65 0.69 0.73 0.77
Q2 0.55 0.61 0.65 0.69 0.73 0.77
Q3 0.55 0.61 0.65 0.69 0.73 0.77
Q4 0.55 0.61 0.65 0.69 0.73 0.77
A 2.2 2.44 2.6 2.76 2.92 3.08
2018 2019 2020 2021 2022 2023
Mar - 2581.2 2536.3 2530.3 2527.7 2538.6
Jun 2690.3 2574.6 2524.1 2532.1 2528.8 2537.4
Sep 2659.5 2560.4 2529.2 2531.4 2533.3 2537.5
Dec 2600.4 2546 2530 2525.9 2535.4 2534

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 3 2.3 2.5 2.4 2.5
Fixed Asset Turnover 1.9 1.6 1.7 2 1.6
Total Asset Turnover 0.5 0.5 0.5 0.6 0.5
Leverage
Debt Ratio 0.8 1 0.9 0.8 0.8
Debt – Equity Ratio 0.6 0.8 1 0.9 0.7
Interest Coverage 4.9 88 6 5.1 3.3
Equity multiplier 0.7 0.8 1.1 0.9 1